drugset / Trial / NCT04856878

Effect of Vancomycin After Catheter Replacement

NCT04856878

Phase 4 Unknown 100 enrolled University of Zurich
RandomizedParallel-groupSingle-blindTreatment

Summary

Randomized controlled trial of the effect of a single-dose intravenous Vancomycin after catheter replacement for suspected central line-associated bloodstream infection on resolution of infection in critically ill patients.

Timeline

Start
2021-06-01
Primary completion
2024-06-30
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Vancomycin Other / unclassified 15 mg/kg Intravenous

Indications

No indication recorded.